Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
Recruiting
Observational Study
Dengue
Dengue Fever
Dengue Fever With Warning Signs
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 5 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Jose Ivan Rodriguez de Molina Serrano · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This 3-year prospective observational study aims to identify clinical and laboratory risk factors associated with hospitalization in patients with confirmed dengue virus infection. It also seeks to analyze real-world transfusion practices and their outcomes. The study will be conducted in a second-level hospital in northern Mexico and will follow patients from emergency department entry to clinica…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged ≥5 years
* Laboratory-confirmed dengue infection (NS1, IgM, or PCR)
* First contact at emergency or outpatient services
* Informed consent signed by the patient or legal guardian
Exclusion Criteria:
* Co-infection with other arboviruses or COVID-19
* Pre-existi…
Contacts
JOSE IVAN RODRIGUEZ DE MOLINA SERRANO, MD, MSc, Ph, Specialist
525525848735
jefe.urgencias@clinicamexico.com
CONTACT